Successful treatment of pachydermoperiostosis with etoricoxib in a patient with a homozygous splice‐site mutation in the SLCO 2A1 gene
Authors:
- 6 December 2018
- journal article
- letter
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 180 (3) , 682-684
Abstract
No abstract availableFunding Information
- Science and Technology Department of Sichuan Province (2014SZ0234)
This publication has 7 references indexed in Scilit:
- Complete form of pachydermoperiostosis withSLCO2A1gene mutation in a Korean familyThe Journal of Dermatology, 2015
- Mutations in theSLCO2A1Gene and Primary Hypertrophic Osteoarthropathy: A Clinical and Biochemical CharacterizationThe Journal of Clinical Endocrinology & Metabolism, 2013
- Exome Sequencing Identifies SLCO2A1 Mutations as a Cause of Primary Hypertrophic OsteoarthropathyThe American Journal of Human Genetics, 2012
- The hippocratic finger points the blame at PGE2Nature Genetics, 2008
- Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathyNature Genetics, 2008
- Pachydermoperiostosis: an updateClinical Genetics, 2005
- The Two-Step Model of Prostaglandin Signal Termination: In Vitro Reconstitution with the Prostaglandin Transporter and Prostaglandin 15 DehydrogenaseMolecular Pharmacology, 2004